Last10K.com

Cytokinetics Inc (CYTK) SEC Filing 8-K Material Event for the period ending Tuesday, February 26, 2019

Cytokinetics Inc

HISTORY TOOLS
CIK: 1061983 Ticker: CYTK

View differences made from one to another to evaluate Cytokinetics Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Cytokinetics Inc.

Continue

Assess how Cytokinetics Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Cytokinetics Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: CYTK
CIK: 1061983
Form Type: 8-K Corporate News
Accession Number: 0001171843-19-001467
Submitted to the SEC: Mon Mar 04 2019 4:15:13 PM EST
Accepted by the SEC: Mon Mar 04 2019
Period: Tuesday, February 26, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/cytk/0001171843-19-001467.htm